80.75 USD
▼+5.04-0.98%
盘后 81.50 -0.06%
2026-08-03
市值
$2.79B
市盈率
20.10
EPS
4.46
股息率
—
52 周区间
60.11 – 156.00
成交量
1.63M
Beta
1.88
目标价
106.00
52W 低 60.1152W 高 156.00
价格走势
公司简介
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company provides Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung tra...